Abstract:Objectives: Tumor necrosis factor superfamily-15 (TNFSF15) also known as vascular endothelial growth inhibitor (VEGI) is a cytokine that modulates anti-angiogenesis and inflammation. Vascular endothelial growth factor (VEGF) promotes angiogenesis and vascular permeability following traumatic brain injury (TBI). The balance of VEGF and VEGI may play a key role in the maintenance of vascular and immune system homeostasis in the brain. However, the dynamic changes of circulating VEGF and VEGI after traumatic brain injury (TBI) and the correlation between plasma VEGF and plasma VEGI remains obscure. In this study, we were to investigate whether circulating VEGF and VEGI can be used as prognostic markers for patients with TBI.Patients and methods: A prospective clinical study was conducted in two neurosurgical intensive care units of Tianjin Medical University General Hospital and Tianjin Huanhu Hospital (Tianjin, China). 40 patients and 30 healthy controls were recruited. The recruited subjects were aged over 18 with randomized gender and GCS. 1 mL of blood was withdrawn on 1, 4, 7, 14, and 21 days after TBI. Blood samples were centrifuged at 3000 rpm and the supernatants were used to measure VEGF and VEGI by ELISA kit.Results: 1) Circulating VEGF in TBI patients was decreased on the 1st day after TBI, then climbed up on the 4th day, reaching a maximum level on the 14th day after TBI, as compared to normal controls. VEGF level returned to normal level on 21th day after TBI. 2) Circulating VEGI in TBI patients was decreased on the 1st and 4th day after TBI, then climbed up on the 7th day after TBI, reaching a maximum level on 14th day after TBI, as compared to normal controls. VEGI levels declined to normal level on 21th day after TBI. 3) There was a significant positive correlation between circulating VEGF and VEGI. 4) However, TBI patients whose conditions had improved exhibited lower VEGF levels 7 days after TBI when compared to TBI patients whose condition had deteriorated. Survivors exhibited higher VEGI levels 7 days after TBI when compared to non-survivors. 5)TBI patients whose condition had improved exhibited higher VEGI levels when compared to TBI patients whose condition had deteriorated 21 days after TBI. Patients with mild TBI exhibited higher VEGI levels than those with moderate and severe TBI 21 days after TBI. 6) A lower rate of recovery and higher hospital mortality were found in patients with VEGF/VEGI ratio >= 2.366 as compared to those with VEGF/VEGI ratio <2.366 7 days after TBI.Conclusions: 1) VEGF level positively correlates with VEGI after TBI. 2) The elevation of VEGF exhibits an adverse effect from 4 to 14 days after TBI while it has an advantageous effect from 14 to 21 days after TBI. Increasing VEGI levels are beneficial in recovery after TBI. Controlling the ratio of VEGF/VEGI may benefit the clinical outcome following TBI. (C) 2016 Elsevier B.V. All rights reserved.

Endothelial Progenitor Cells Correlate with Clinical Outcome of Traumatic Brain Injury.

Change in Plasma Microparticle Procoagulant Activity after Traumatic Brain Injury

Plasma copeptin concentration and outcome after pediatric traumatic brain injury.

The Role of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Inhibitor in Clinical Outcome of Traumatic Brain Injury

Circulating endothelial progenitor cells in traumatic brain injury: an emerging therapeutic target?

Study on the dynamic changes of endothelial progenitor cells in peripheral blood and cognitive ability of rats with different degrees of traumatic brain injury

Decreased Numbers of Circulating Endothelial Progenitor Cells Are Associated with Hyperglycemia in Patients with Traumatic Brain Injury

Endostatin/Collagen XVIII is Increased in Cerebrospinal Fluid after Severe Traumatic Brain Injury

Mobilization of Circulating Endothelial Progenitor Cells after Endovascular Therapy for Ruptured Cerebral Aneurysms.

Multiplex Assessment of Serum Chemokines CCL2, CCL5, CXCL1, CXCL10, and CXCL13 Following Traumatic Brain Injury

Platelet Contribution and Endothelial Activation and Stress Index-Potential Mortality Predictors in Traumatic Brain Injury

Beyond brain injury biomarkers: chemoattractants and circulating progenitor cells as biomarkers of endogenous rehabilitation effort in preterm neonates with encephalopathy

Progesterone increases circulating endothelial progenitor cells and induces neural regeneration after traumatic brain injury in aged rats.

The Prognostic Value of Deleted in Colorectal Cancer (DCC) Receptor and Serum Netrin-1 in Severe Traumatic Brain Injury

Novel severe traumatic brain injury blood outcome biomarkers identified with proximity extension assay

Clinical Predictors of Prognosis in Patients with Traumatic Brain Injury Combined with Extracranial Trauma

Utility of serum chemokine–like factor 1 as a biomarker of severity and prognosis after severe traumatic brain injury: A prospective observational study

Predictive value of intracranial pressure-related parameters and coagulation on the prognosis in patients with traumatic brain injury.

Endothelial progenitor cell transplantation alleviated ischemic brain injury via inhibiting C3/C3aR pathway in mice

Changes of Circulating Endothelial Progenitor Cells and Their Clinical Significance in Patients with Acute Cerebral Infarction

Effects of Atorvastatin in the Regulation of Circulating EPCs and Angiogenesis in Traumatic Brain Injury in Rats.